Sudeep Pharma's Rs 895 crore IPO, featuring a Rs 95 crore fresh issue and Rs 800 crore OFS, closes today. With a price band of Rs 563-593, the issue has seen strong demand, subscribing 5.13 times overall, driven by retail and NIIs, while QIB interest remains subdued. Brokerages are divided, citing sector growth potential against expensive valuations, with grey market premium indicating moderate listing gains.